GURUFOCUS.COM » STOCK LIST » Technology » Hardware » DorsaVi Ltd (ASX:DVL) » Definitions » COGS-to-Revenue

DorsaVi (ASX:DVL) COGS-to-Revenue : 0.09 (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is DorsaVi COGS-to-Revenue?

DorsaVi's Cost of Goods Sold for the six months ended in Dec. 2024 was A$0.06 Mil. Its Revenue for the six months ended in Dec. 2024 was A$0.65 Mil.

DorsaVi's COGS to Revenue for the six months ended in Dec. 2024 was 0.09.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. DorsaVi's Gross Margin % for the six months ended in Dec. 2024 was 90.98%.


DorsaVi COGS-to-Revenue Historical Data

The historical data trend for DorsaVi's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DorsaVi COGS-to-Revenue Chart

DorsaVi Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.09 0.12 0.14 0.09

DorsaVi Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.16 0.13 0.06 0.09

DorsaVi COGS-to-Revenue Calculation

DorsaVi's COGS to Revenue for the fiscal year that ended in Jun. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.123 / 1.304
=0.09

DorsaVi's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.059 / 0.654
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DorsaVi  (ASX:DVL) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

DorsaVi's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.059 / 0.654
=90.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


DorsaVi COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of DorsaVi's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


DorsaVi Business Description

Traded in Other Exchanges
N/A
Address
11-13 Milgate Street, Unit 3, Oakleigh South, Melbourne, VIC, AUS, 3167
DorsaVi Ltd is engaged in the development and sale of motion analysis technologies. Its technologies are commercialized via license, sale, or fixed-fee consultancy. The company makes wearable sensors, software, and sophisticated algorithms that measure movement and muscle activation at around 200 frames per second. The company's products include ViSafe (Workplace), ViMove (Clinic), and others. The firm operates in two reportable segments: Clinical, and Workplace. A majority of its revenue is generated from the Clinical segment. Geographically, the company derives maximum revenue from the United States of America, and the rest from Australia, and Europe.

DorsaVi Headlines

No Headlines